What is MitoAction?
MitoAction operates as a critical nexus for the mitochondrial disease community, providing a comprehensive suite of support services, educational resources, and advocacy initiatives. The organization distinguishes itself through high-impact programs such as the Mito411 support line, expert-led educational series, and the MyMito digital application, which serves as a vital tool for patient and caregiver management. By bridging the gap between clinical research and patient-centric care, MitoAction has established itself as a leader in the health advocacy sector, driving measurable improvements in patient outcomes and community engagement.
How much funding has MitoAction raised?
MitoAction has raised a total of $39K across 1 funding round:
Debt
$39K
Debt (2021): $39K with participation from PPP
Key Investors in MitoAction
PPP
Public-Private Partnership
What's next for MitoAction?
With the recent infusion of capital, MitoAction is poised to accelerate its strategic roadmap, focusing on the expansion of its digital health tools and the broadening of its clinical research outreach. The organization aims to deepen its impact by scaling its advocacy efforts to reach a wider demographic, while simultaneously enhancing the technical capabilities of its existing support platforms. As the entity moves into this next phase of growth, the focus will remain on fostering sustainable partnerships and driving innovation in the management of mitochondrial conditions, ultimately empowering the community through data-driven support and robust educational frameworks.
See full MitoAction company page
